脑部放疗,上午比下午敏感许多!$ }! \( a. Q8 E( j
' z* _9 @8 O7 O
# m$ ~- [& ^$ P* f, QCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.! i& q, w( Q c4 N$ c9 v' \8 ~
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?% a" F* `3 f& l$ G
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
; N4 c! K T4 j/ ~8 p$ m) y% aSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
- W. R a5 U6 m) Z
" x3 S9 l" B% I8 r: j" D1 eAbstract
6 f# H! l) @ L/ U+ g2 J1 }+ iBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
9 _8 p! T9 L3 A. c$ \
1 K# } w3 N" O' u |% c; w6 ?METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic., _) o7 [3 P- C; l7 N% K5 z" c
8 M) U f5 f/ N9 W( n5 D: `9 oRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).( p/ m2 ?, R2 b! q5 F
2 \ N# K0 e, z" f- E! Z& J
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
, d$ Z6 F9 a& M/ G6 n) b! W1 h6 Y' t, @+ w1 j
|